• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Caring Brands Inc.

    4/10/26 4:30:33 PM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CABR alert in real time by email
    false 0002020737 0002020737 2026-04-07 2026-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): April 7, 2026

     

    Caring Brands, Inc.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-42941   99-4103908

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    130 S Indian River Drive,

    Suite 202 pbm# 1232,

    Fort Pierce, FL 34950

    (Address of principal executive offices, including zip code)

     

    Registrant’s telephone number, including area code: (561) 896-7616

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
             
    Common Stock, par value $0.001 per share   CABR   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On April 7, 2026, Caring Brands, Inc. (the “Company”) received a Staff Delisting Determination letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on The Nasdaq Capital Market (the “Stockholders’ Equity Rule”), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. The Company’s failure to comply with the Stockholders’ Equity Rule was based on the Company’s filing of its Annual Report on Form 10-K for the year ended December 31, 2025, reporting a stockholders’ equity of $2,091,324.

     

    In accordance with Nasdaq Listing Rules, the Company has been provided with an initial period of 45 calendar days, or until May 22, 2026, to submit a plan to regain compliance with the Stockholders’ Equity Rule. Subsequent to the receipt of the Notice, and prior to that deadline, the Company intends to submit a plan to regain compliance with the Stockholders’ Equity Rule to Nasdaq. If the Company’s compliance plan is accepted by Nasdaq, then Nasdaq may, in its discretion, grant the Company up to 180 calendar days from the date of the Notice, or until October 4, 2026, to evidence compliance.

     

    Neither the Notice nor the Company’s non-compliance have an immediate effect on the listing or trading of the Company’s common stock, which will continue to trade under the symbol “CABR.” The Company intends to take all reasonable measures available to regain compliance under the Stockholders’ Equity Rule and remain listed on Nasdaq. However, there can be no assurance that the Company’s plan will be accepted or that if it is, the Company will be able to regain compliance. If the Company’s plan to regain compliance is not accepted, or if it is and the Company does not regain compliance within 180 days from the date of the Notice, or if the Company fails to satisfy another Nasdaq requirement for continued listing, Nasdaq could provide notice that the Company’s common stock will become subject to delisting.

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or the future financial performance of the Company and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “projects,” “potential,” “continues,” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding the Company’s intent to submit a plan to regain compliance with the Stockholders’ Equity Rule within 45 calendar days and the Company’s ability to regain compliance with the Stockholders’ Equity Rule by the deadline imposed by Nasdaq.

     

    These forward-looking statements reflect the Company’s current expectations and projections based on information available as of the date of this Current Report on Form 8-K and are subject to a number of risks and uncertainties, including, but not limited to, general economic, financial, and business conditions; changes in consumer demand and industry trends; the Company’s ability to successfully implement its strategic initiatives; competition in the relevant market; supply chain disruptions; regulatory compliance and legal proceedings; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. The Company cautions investors that forward-looking statements are not guarantees of future performance and actual results may differ materially from those projected. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: April 10, 2026 Caring Brands, Inc.
         
      By: /s/ Glynn Wilson
      Name: Dr. Glynn Wilson
      Title: Chief Executive Officer

     

     

     

    Get the next $CABR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CABR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CABR
    SEC Filings

    View All

    SEC Form 8-K filed by Caring Brands Inc.

    8-K - Caring Brands, Inc. (0002020737) (Filer)

    4/10/26 4:30:33 PM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-K filed by Caring Brands Inc.

    10-K - Caring Brands, Inc. (0002020737) (Filer)

    3/31/26 8:44:29 AM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    Caring Brands Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Caring Brands, Inc. (0002020737) (Filer)

    3/31/26 7:53:35 AM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    $CABR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wilson Glynn

    4 - Caring Brands, Inc. (0002020737) (Issuer)

    3/27/26 6:56:31 PM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by John Brian

    4 - Caring Brands, Inc. (0002020737) (Issuer)

    3/27/26 6:56:15 PM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by Director Alila Hector W

    4 - Caring Brands, Inc. (0002020737) (Issuer)

    12/16/25 8:33:36 AM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    $CABR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology

    Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (NASDAQ:CABR) today announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company's intellectual property portfolio supporting its Hair Enzyme Booster product. The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase sulfotransferase enzyme activity to improve the efficacy of topical hair loss treatments. These patents expand Caring Brands' exclusive protection around mechanisms that are central to the Hair Enzy

    2/3/26 8:25:00 AM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl

    Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (NASDAQ:CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis's over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume responsibility for product manufacturing, marketing, sales strategy, and global distribution. Itonis will provide technical information, product formulation data, historical sales information, and intell

    1/5/26 8:30:00 AM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary

    Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq

    FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. ("Caring Brands" or the "Company"), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the closing of its underwritten U.S. public offering of 1,000,000 shares of common stock at a public offering price of $4.00 per share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the "Offering"). The shares of common stock commenced trading on the Nasdaq Capital Markets on November 13, 2025 under the ticker symbol "CABR". In addition, the Company has granted the underwriter a 45

    11/14/25 5:00:00 PM ET
    $CABR
    Package Goods/Cosmetics
    Consumer Discretionary